← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 8, 2017Last known activity
May 28, 2024
Timeline
1990s
- Jan 1, 1991
Achieve Life Sciences— Founded
2010s
- Aug 1, 2017
OncoGenex Technologies— Acquired
Drugs by trial phase (17 distinct, 36 trials)
Phase 3 (1 own, 7 via acquisition)
Phase 2 (1 own, 6 via acquisition)
Phase 1 (0 own, 2 via acquisition)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (15)
- NCT06435221OfficialPhase 3May 28, 2024
- NCT06435221Lead sponsorPhase 3May 28, 2024
- NCT05981768Lead sponsorPhase 1Aug 8, 2023
- NCT05631938Lead sponsorPhase 1Jan 30, 2023
- NCT05566288Lead sponsorPhase 1Oct 17, 2022
- NCT05431387Study directorPhase 2Jul 13, 2022
- NCT05431387Lead sponsorPhase 2Jul 13, 2022
- NCT05206370Study directorPhase 3Jan 20, 2022
- NCT05206370Lead sponsorPhase 3Jan 20, 2022
- NCT04576949Lead sponsorPhase 3Oct 13, 2020
- NCT03848208Lead sponsorPhase 1Feb 28, 2019
- NCT03709823Lead sponsorPhase 2Nov 13, 2018
- NCT03509948Lead sponsorPhase 1Apr 27, 2018
- NCT03303911Lead sponsorPhase 1/Phase 2Oct 6, 2017
- NCT03268343Lead sponsorPhase 1Aug 8, 2017
Details
- Founded
- Mill Valley, CA, US Jan 1, 1991
- Last known activity
- May 28, 2024